医学捌号楼
 
Web www.med8th.com
医学捌号楼·医疗资讯·美国Welch Allyn AED20自动体外心脏去纤颤器的第一级回收通知
美国Welch Allyn AED20自动体外心脏去纤颤器的第一级回收通知
www.med8th.com  |  2006年6月21日

香港卫生署,美国食物及药物管理局发出关于Welch Allyn AED20自动体外心脏去纤颤器的第一级回收通知。受影响的仪器包括序号由 205199 至 205786 的体外心脏去纤颤器。详情请参阅美国食物及药物管理局的网页(只限英文):

http://www.fda.gov/cdrh/recalls/recall-061506.html

Welch Allyn AED 20? Automated External Defibrillators

Class 1 Medical Device Recalls - Welch Allyn AED 20? Automated External Defibrillators

Date Recall Initiated: June 15, 2006

Product: Welch Allyn AED 20? Automated External Defibrillators manufactured from April through October 2003, serial numbers 205199 through 205786.

Use: These devices are intended for use by emergency or medical personnel to treat adult and pediatric patients in cardiopulmonary arrest (heart attack). The devices analyze an unconscious patient’s heart rhythm and automatically deliver an electrical shock to the heart if needed to restore normal heart rhythm.

Recalling Firm: MRL, Inc., A Welch Allyn company

1000 Asbury Drive

Suite 17

Buffalo Grove, IL 60089-4551

Reason for Recall: An electrical connection within the recalled devices may fail intermittently, impairing the device's ability to analyze the patient’s heart rhythm and deliver appropriate therapy. This could result in delay or failure to resuscitate the patient. This may be associated with an error message on the device display reading “DEFIB COMM FAIL SELF TEST FAILED.”

Public Contact: Questions can be directed to the company at (800)462-0777 or (847)520-0300 for more information.

FDA District: Chicago

FDA Comments:

  • MRL, Inc sent letters via certified mail on June 14, 2006 to its customers who purchased AED20’s in this group of devices.
  • Owners of this defibrillator should contact MRL, Inc. to obtain a loaner AED20 at no cost while their unit is being serviced.
  • MRL, Inc. will pay all costs associated with shipping, handling and replacement of the units’ “DEFIB” board.

Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of the product will cause serious injury or death.

For additional information on this product recall, see the company’s press release at http://www.fda.gov/oc/po/firmrecalls/mrl06_06.html.

Updated June 16, 2006

相关内容
Sorin集团强调创新性起搏技术——AAIsafeR(TM)
广西人民医院完成非体外循环微创房间隔缺损封堵术
回收“Cytosol Ophthalmics” Balanced Salt Solution
《体外诊断检验系统自测用血糖监测系统通用技术条件》国家标准第1号修改单
浙医一院成功开展三维立体标测指导下的房颤导管消融治疗
陈义汉教授《心房颤动分子遗传学和细胞电生理学研究》项目荣获国家自然 ...
广东省人院成功应用体外膜肺氧合(ECMO)技术
新技术为更多房颤患者带来希望
rt-PA溶栓术救治重症心肌梗死病人
(SAHAJANAND-MEDICAL-TECH) SMT药物洗脱支架获欧共体药物评价委员会认可
辽宁省人院为病人置入抗房颤起搏器取得成功
上气道压力测定综合术前评估手段提高鼾症手术成功率
佛山市一院又一例颈动脉支架放置成功
欧姆龙自愿回收两个型号的电子体温计
破裂血管穿上“保护内衣” 危重血管瘤患者有救了
部分型号的植入式心脏去纤颤器或有问题
北京人民医院完成三维立体标测指导下的房颤射频消融治疗
Guidant INSIGNIA 及NEXUS心脏起搏器安全资讯
LifeScan主动回收及更换部分血糖监测产品
浙江医院开展软腭支架植入术治疗鼾症
浙江省人院为血管瘤患者做心脏带膜支架术
美国佳腾公司宣布召回部分心脏除颤器
FDA宣告Baxter Healthcare回收Colleague定量输注泵
北医三院应用体外膜肺氧合和双心室辅助装置救治心肌梗死
Guidant更换心脏起搏器资讯
机器人辅助微创房间隔缺损封堵术成功
湘雅医院为2个月新生儿作大动脉调转术成功
Guidant公司全球回收部分植入式心脏去纤颤器
 
Web www.med8th.com